GB1406061A - Medicament formulations containing 6-alkoxypyridzinium compounds - Google Patents

Medicament formulations containing 6-alkoxypyridzinium compounds

Info

Publication number
GB1406061A
GB1406061A GB3649972A GB3649972A GB1406061A GB 1406061 A GB1406061 A GB 1406061A GB 3649972 A GB3649972 A GB 3649972A GB 3649972 A GB3649972 A GB 3649972A GB 1406061 A GB1406061 A GB 1406061A
Authority
GB
United Kingdom
Prior art keywords
alkoxypyridzinium
compounds
formulations containing
aug
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3649972A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of GB1406061A publication Critical patent/GB1406061A/en
Expired legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1406061 Pharmaceutical compositions BASF AG 4 Aug 1972 [7 Aug 1971] 36499/72 Addition to 1293022 Heading A5B A formulation for use as a cardiac stimulating or vasopressor agent comprises as active ingredient a compound of the formula in which R is alkyl or 1 to 4 carbon atoms and X- is one equivalent of a therapeutically acceptable anion. The formulation may be in a form suitable for oral or parenteral use and may be in unit dosage form. Other active ingredients such as caffeine or analgesic agents may also be present.
GB3649972A 1971-08-07 1972-08-04 Medicament formulations containing 6-alkoxypyridzinium compounds Expired GB1406061A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712139687 DE2139687C2 (en) 1971-08-07 1971-08-07 Use of compounds in increasing blood pressure

Publications (1)

Publication Number Publication Date
GB1406061A true GB1406061A (en) 1975-09-10

Family

ID=5816135

Family Applications (2)

Application Number Title Priority Date Filing Date
GB3649972A Expired GB1406061A (en) 1971-08-07 1972-08-04 Medicament formulations containing 6-alkoxypyridzinium compounds
GB1315075A Expired GB1406062A (en) 1971-08-07 1972-08-04 Medicament formulations containing 6-methoxypyridazinium compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB1315075A Expired GB1406062A (en) 1971-08-07 1972-08-04 Medicament formulations containing 6-methoxypyridazinium compounds

Country Status (5)

Country Link
BE (1) BE787275A (en)
DE (1) DE2139687C2 (en)
FR (1) FR2150745B1 (en)
GB (2) GB1406061A (en)
ZA (1) ZA725359B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820821A (en) * 1981-11-06 1989-04-11 Basf Aktiengesellschaft Novel pyridazinone-imines and their physiologically tolerated addition salts with acids, their preparation and therapeutic agents containing these compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1912941C3 (en) * 1969-03-14 1980-06-26 Basf Ag, 6700 Ludwigshafen 1-phenyl ^ -amino-e-methoxypyridazinium salts

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820821A (en) * 1981-11-06 1989-04-11 Basf Aktiengesellschaft Novel pyridazinone-imines and their physiologically tolerated addition salts with acids, their preparation and therapeutic agents containing these compounds

Also Published As

Publication number Publication date
ZA725359B (en) 1973-05-30
FR2150745B1 (en) 1976-08-20
BE787275A (en) 1973-02-07
FR2150745A1 (en) 1973-04-13
GB1406062A (en) 1975-09-10
DE2139687C2 (en) 1985-01-24
DE2139687A1 (en) 1973-02-15

Similar Documents

Publication Publication Date Title
GB1271302A (en) New pyridyl-oxadiazole derivatives and process for the preparation thereof and pharmaceutical compositions containing same
NZ330369A (en) aqueous medicaments containing 9-hydroxy-risperidone fatty acid ester
GB1418208A (en) Pharmaceutical compositions
GB1081577A (en) Scopolamine esters and acid addition salts thereof useful as anti-perspirant agents
GB1399834A (en) Pharmaceutical compositions
GB1487334A (en) Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof
GB1174051A (en) Aminophenol Derivatives and Analgesic and Antipyretic Compositions
GB1406061A (en) Medicament formulations containing 6-alkoxypyridzinium compounds
OA07029A (en) Gallium chloride, a new anti-cancer drug.
GB1464467A (en) Pharmaceutical composition for the treatment of coronary
GB1322112A (en) 3,4,5-trimethoxybenzoic acid derivatives and their uses
GB1160597A (en) Novel Isoxazolo[5,4-6]Pyridines and the Preparation Thereof
KR930023338A (en) Depo formulation
IE39679B1 (en) Methods and compositions for killing parasites of warm blooded animals
ES342394A1 (en) Novel Benzylaminoimidazoline Derivatives, the preparation thereof and Compositions containing the same
GB1352392A (en) Phenylisopropylamine derivatives
ES363591A1 (en) beta-PHENETHYLAMINE DERIVATIVES AND A PROCESS FOR THE MANUFACTURE THEREOF
GB1359044A (en) Quinoline derivatives
GB1464082A (en) Pharmaceutical 'ompositions containing benzylamines
GB1375806A (en)
GB1176049A (en) N-Substituted Noratropinium Salts
ES393894A1 (en) Piperidinemethyl ethers
GB1465771A (en) Pharmaceutical composition and use thereofd
GB1420976A (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
GB1279380A (en) Improvements in or relating to hydantoins and compositions thereof

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee